These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

231 related items for PubMed ID: 8174842

  • 21. The relationship of glycemic exposure (HbA1c) to the risk of development and progression of retinopathy in the diabetes control and complications trial.
    Diabetes; 1995 Aug; 44(8):968-83. PubMed ID: 7622004
    [Abstract] [Full Text] [Related]

  • 22. Alcohol consumption and risk of microvascular complications in type 1 diabetes patients: the EURODIAB Prospective Complications Study.
    Beulens JW, Kruidhof JS, Grobbee DE, Chaturvedi N, Fuller JH, Soedamah-Muthu SS.
    Diabetologia; 2008 Sep; 51(9):1631-8. PubMed ID: 18626626
    [Abstract] [Full Text] [Related]

  • 23. Plasma lipids and urinary albumin excretion rate in Type 1 diabetes mellitus: the EURODIAB IDDM Complications Study.
    Mattock MB, Cronin N, Cavallo-Perin P, Idzior-Walus B, Penno G, Bandinelli S, Standl E, Kofinis A, Fuller JH, EURODIAB IDDM Complications Study.
    Diabet Med; 2001 Jan; 18(1):59-67. PubMed ID: 11168343
    [Abstract] [Full Text] [Related]

  • 24. Relations between diabetic retinopathy and cardiovascular neuropathy--a cross-sectional study in IDDM and NIDDM patients.
    Zander E, Heinke P, Herfurth S, Reindel J, Ostermann FE, Kerner W.
    Exp Clin Endocrinol Diabetes; 1997 Jan; 105(6):319-26. PubMed ID: 9439926
    [Abstract] [Full Text] [Related]

  • 25. The relation between QTc interval prolongation and diabetic complications. The EURODIAB IDDM Complication Study Group.
    Veglio M, Borra M, Stevens LK, Fuller JH, Perin PC.
    Diabetologia; 1999 Jan; 42(1):68-75. PubMed ID: 10027581
    [Abstract] [Full Text] [Related]

  • 26. Cardiovascular disease and its risk factors in IDDM in Europe. EURODIAB IDDM Complications Study Group.
    Koivisto VA, Stevens LK, Mattock M, Ebeling P, Muggeo M, Stephenson J, Idzior-Walus B.
    Diabetes Care; 1996 Jul; 19(7):689-97. PubMed ID: 8799621
    [Abstract] [Full Text] [Related]

  • 27. Microalbuminuria is not rare before 5 years of IDDM. EURODIAB IDDM Complications Study Group and the WHO Multinational Study of Vascular Disease in Diabetes Study Group.
    Stephenson JM, Fuller JH.
    J Diabetes Complications; 1994 Jul; 8(3):166-73. PubMed ID: 8086653
    [Abstract] [Full Text] [Related]

  • 28. Blood pressure, retinopathy and urinary albumin excretion in IDDM: the EURODIAB IDDM Complications Study.
    Stephenson JM, Fuller JH, Viberti GC, Sjolie AK, Navalesi R.
    Diabetologia; 1995 May; 38(5):599-603. PubMed ID: 7489844
    [Abstract] [Full Text] [Related]

  • 29. The relationship of prorenin values to microvascular complications in patients with insulin-dependent diabetes mellitus.
    Davies L, Fulcher GR, Atkins A, Frumar K, Monaghan J, Stokes G, Clifton-Bligh P, McElduff A, Robinson B, Stiel J, Twigg S, Wilmshurst E.
    J Diabetes Complications; 1999 May; 13(1):45-51. PubMed ID: 10232709
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. Can glycaemic variability, as calculated from blood glucose self-monitoring, predict the development of complications in type 1 diabetes over a decade?
    Bragd J, Adamson U, Bäcklund LB, Lins PE, Moberg E, Oskarsson P.
    Diabetes Metab; 2008 Dec; 34(6 Pt 1):612-6. PubMed ID: 18824382
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. Electrocardiographic left ventricular hypertrophy in type 1 diabetes: prevalence and relation to coronary heart disease and cardiovascular risk factors: the Eurodiab IDDM Complications Study.
    Giunti S, Bruno G, Veglio M, Gruden G, Webb DJ, Livingstone S, Chaturvedi N, Fuller JH, Perin PC, Eurodiab IDDM Complications Study.
    Diabetes Care; 2005 Sep; 28(9):2255-7. PubMed ID: 16123503
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. [Coronary risk factors in a group of patients with insulin dependent diabetes mellitus--examination of the EURODIAB IDDM Complications Study Krakow].
    Idzior-Waluś B, Solnica B, Szopinska-Ciba L, Sieradzki J.
    Przegl Lek; 1994 Sep; 51(11):468-74. PubMed ID: 7871192
    [Abstract] [Full Text] [Related]

  • 36. Type 1 diabetes mellitus in Catalonia: chronic complications and metabolic control ten years after onset.
    Cantón A, Fernández Castańer M, Conget I, Carreras G, Castell C, Tresserras R.
    Med Sci Monit; 2004 May; 10(5):CR185-90. PubMed ID: 15114267
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. Hyperhomocyst(e)inemia and endothelial dysfunction in IDDM.
    Hofmann MA, Kohl B, Zumbach MS, Borcea V, Bierhaus A, Henkels M, Amiral J, Schmidt AM, Fiehn W, Ziegler R, Wahl P, Nawroth PP.
    Diabetes Care; 1998 May; 21(5):841-8. PubMed ID: 9589252
    [Abstract] [Full Text] [Related]

  • 40. Diabetes care, glycemic control, and complications in children with type 1 diabetes from Asia and the Western Pacific Region.
    Craig ME, Jones TW, Silink M, Ping YJ.
    J Diabetes Complications; 2007 May; 21(5):280-7. PubMed ID: 17825751
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 12.